OptimizeRx (OPRX) Income towards Parent Company (2016 - 2026)
OptimizeRx's Income towards Parent Company history spans 16 years, with the latest figure at $5.0 million for Q4 2025.
- On a quarterly basis, Income towards Parent Company rose 6535.9% to $5.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.1 million, a 125.52% increase, with the full-year FY2025 number at $5.1 million, up 125.52% from a year prior.
- Income towards Parent Company hit $5.0 million in Q4 2025 for OptimizeRx, up from $779000.0 in the prior quarter.
- Over the last five years, Income towards Parent Company for OPRX hit a ceiling of $5.0 million in Q4 2025 and a floor of -$11.7 million in Q4 2023.
- Historically, Income towards Parent Company has averaged -$2.6 million across 5 years, with a median of -$2.5 million in 2023.
- Biggest five-year swings in Income towards Parent Company: plummeted 8790.01% in 2022 and later skyrocketed 6535.9% in 2025.
- Tracing OPRX's Income towards Parent Company over 5 years: stood at $623462.0 in 2021, then crashed by 152.26% to -$325836.0 in 2022, then tumbled by 3503.04% to -$11.7 million in 2023, then surged by 99.34% to -$78000.0 in 2024, then skyrocketed by 6535.9% to $5.0 million in 2025.
- Business Quant data shows Income towards Parent Company for OPRX at $5.0 million in Q4 2025, $779000.0 in Q3 2025, and $1.5 million in Q2 2025.